Search Login Register
Histiocytic Sarcoma
Summary
Description:
Malignant neoplasms composed of MACROPHAGES or DENDRITIC CELLS. Most histiocytic sarcomas present as localized tumor masses without a leukemic phase. Though the biological behavior of these neoplasms resemble lymphomas, their cell lineage is histiocytic not lymphoid.
Also Known As:
True Histiocytic Lymphoma; True Malignant Histiocytosis; Histiocytic Lymphoma, True; Histiocytic Lymphomas, True; Histiocytic Sarcomas Show All >>
Networked: 286
relevant articles (12 outcomes,
25 trials/studies)
for this Disease
Key Drugs and Agents for Histiocytic Sarcoma
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Nimustine
:
2 outcomes in 2 results
: IBA
-
Lomustine (CCNU)
:
1 outcome 2 studies in 6 results
:
FDA 1
-
OPPA protocol
:
1 outcome 1 study in 1 result
: IBA
-
Doxorubicin (Adriamycin)
:
1 outcome in 6 results
:
FDA 12
Generic
-
Thalidomide (Thalomid)
:
1 outcome in 5 results
:
FDA 2
-
Vincristine (Oncovin)
:
1 outcome in 3 results
:
FDA 17
Generic
-
Cyclophosphamide (Cytoxan)
:
1 outcome in 3 results
:
FDA 10
Generic
-
Cytarabine (Cytosar-U)
:
1 outcome in 2 results
:
FDA 13
Generic
-
Prednisolone (Predate)
:
1 outcome in 1 result
:
FDA 55
Generic
-
Antigens
:
3 studies in 20 results
: IBA
Show All >>
Diseases Related to Histiocytic Sarcoma
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
-
Hyperpigmentation
-
Fever (Fevers)
-
Neoplasms (Cancer)
-
Lymphoma (Lymphomas)
Show All >>
Key Therapies for Histiocytic Sarcoma
Efficacy Chart >>
-
Combination Drug Therapy (Combination Chemotherapy)
:
2 outcomes 1 study in 9 results
-
Bone Marrow Transplantation (Transplantation, Bone Marrow)
:
2 outcomes in 8 results
-
Drug Therapy (Chemotherapy)
:
1 outcome in 18 results
-
Transplantation (Transplant Recipients)
:
1 outcome in 6 results
-
Stem Cell Transplantation
:
1 outcome in 1 result
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.